Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000203034 | SCV000257793 | uncertain significance | not specified | 2015-06-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000879756 | SCV001022808 | likely benign | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000879756 | SCV001817036 | likely benign | not provided | 2021-04-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002517344 | SCV003717193 | uncertain significance | Inborn genetic diseases | 2022-07-20 | criteria provided, single submitter | clinical testing | The c.1712C>G (p.S571C) alteration is located in exon 1 (coding exon 1) of the TPRN gene. This alteration results from a C to G substitution at nucleotide position 1712, causing the serine (S) at amino acid position 571 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |